Filtered By:
Vaccination: Shingles (Herpes Zoster) Vaccine

This page shows you your search results in order of relevance. This is page number 15.

Order by Relevance | Date

Total 2063 results found since Jan 2013.

Post-licensure zoster vaccine effectiveness against herpes zoster and postherpetic neuralgia in older adults: a systematic review and meta-analysis
This study is registered on PROSPERO, CRD42021232383.FINDINGS: Our search identified 1240 studies, of which 1162 were excluded based on title and abstract screening. A further 56 articles were excluded on reading the full text. 22 studies (21 cohort studies and one case-control study, involving 9 536 086 participants and 3ยท35 million person-years in the USA, UK, Canada, and Sweden) were included in the quantitative analysis. Of these, 13 articles were included in the meta-analysis. The overall quality of evidence was very low for all outcomes. The pooled vaccine effectiveness for ZVL against herpes zoster in adults was 45...
Source: Herpes - September 13, 2022 Category: Infectious Diseases Authors: James F Mbinta Binh P Nguyen Prosper Mandela A Awuni Janine Paynter Colin R Simpson Source Type: research

Development of varicella vaccine in Japan and future prospects.
Abstract In Japan, Dr. Michiaki Takahashi (1928-2013) successfully developed the first live attenuated varicella vaccine in the world. The virus used for this vaccine was varicella-zoster virus isolated from the vesicular fluid of a child with typical varicella and it was named the Oka strain after the family name of the child. In 1974, a patient with nephrosis developed varicella in the Pediatric Ward, and uninfected pediatric patients received varicella vaccine immediately. As a result, there were no cases of varicella in the other children and all of the vaccinated children acquired immunity to the disease. The...
Source: Vaccine - May 5, 2016 Category: Allergy & Immunology Authors: Ozaki T, Asano Y Tags: Vaccine Source Type: research

Development of a perfusion process for serum-free adenovirus vector herpes zoster vaccine production
AMB Express. 2022 May 14;12(1):58. doi: 10.1186/s13568-022-01398-7.ABSTRACTHerpes zoster is caused by reactivation of the varicella zoster virus (VZV). Researching and developing a herpes zoster vaccine will help to decrease the incidence of herpes zoster. To increase the bioreactor productivity, a serum-free HEK293 cell perfusion process with adenovirus vector herpes zoster (rAd-HZ) vaccine production was developed efficiently using the design of experiment (DoE) method. First, serum-free media for HEK293 cells were screened in both batch and semi-perfusion culture modes. Then, three optimal media were employed in a mediu...
Source: Herpes - May 14, 2022 Category: Infectious Diseases Authors: Yang Sun Lingling Huang Jianqi Nie Kai Feng Yupeng Liu Zhonghu Bai Source Type: research

Immunization for midlife women
Conclusions Disease prevention benefits are well established for several diseases, such as hepatitis A, hepatitis B, tetanus, human papillomavirus, streptococcus pneumonia, shingles, and COVID-19. During clinical encounters, a needs assessment regarding vaccinations should be conducted. However, barriers to adult vaccination including lack of patient and provider knowledge about the need for vaccination, lack of priority for preventive services, and concerns regarding costs, insurance coverage, and reimbursement all contribute to the adult immunization gap. Given the importance of immunization and the need to decrease ...
Source: Menopause - September 30, 2022 Category: OBGYN Tags: Clinical Corner: Invited Review Source Type: research

Impacts of routine varicella vaccination program and COVID-19 pandemic on varicella and herpes zoster incidence and health resource use among children in Japan
CONCLUSIONS: Varicella incidence and healthcare resource use were largely affected by the routine immunization program and infection prevention measures against COVID-19, while these impacts on herpes zoster were relatively small. Our study indicates that immunization and infection prevention measures largely changed pediatric infectious disease practices.PMID:37400282 | DOI:10.1016/j.vaccine.2023.06.054
Source: Vaccine - July 3, 2023 Category: Allergy & Immunology Authors: Kazuhiro Uda Yusuke Okubo Mitsuru Tsuge Hirokazu Tsukahara Isao Miyairi Source Type: research

Dermatological manifestations associated with COVID-19 and COVID-19 vaccination: results from the Lebanese COVID registry
CONCLUSION: This Lebanese registry adds more robust evidence that clinical manifestations of the COVID-19 virus and vaccine are diverse. More studies are necessary to establish the pathophysiology of these dermatological findings in the context of COVID-19 infection and vaccination.PMID:37638543 | DOI:10.1111/ijd.16815
Source: Herpes - August 28, 2023 Category: Infectious Diseases Authors: Remie Chrabieh Isabelle Haddad Pascale Salameh Mazen Kurban Elio Kechichian Maya Habre Nakhle Ayoub Gretta Torbey Fouad El Sayed Micheline Maamari Zeina Tannous Anna Farra Lebanese COVID Rash Consortium Jinane El Khoury Source Type: research

Surveillance of Vaccination Coverage Among Adult Populations -United States, 2018
MMWR Surveill Summ. 2021 May 14;70(3):1-26. doi: 10.15585/mmwr.ss7003a1.ABSTRACTPROBLEM/CONDITION: Adults are at risk for illness, hospitalization, disability and, in some cases, death from vaccine-preventable diseases, particularly influenza and pneumococcal disease. CDC recommends vaccinations for adults on the basis of age, health conditions, prior vaccinations, and other considerations. Updated vaccination recommendations from CDC are published annually in the U.S. Adult Immunization Schedule. Despite longstanding recommendations for use of many vaccines, vaccination coverage among U.S. adults remains low.REPORTING PER...
Source: MMWR Surveill Summ - May 13, 2021 Category: Epidemiology Authors: Peng-Jun Lu Mei-Chuan Hung Anup Srivastav Lisa A Grohskopf Miwako Kobayashi Aaron M Harris Kathleen L Dooling Lauri E Markowitz Alfonso Rodriguez-Lainz Walter W Williams Source Type: research